Tokyo - Delayed Quote JPY
H.U. Group Holdings, Inc. (4544.T)
3,002.00
+54.00
+(1.83%)
At close: May 23 at 3:30:00 PM GMT+9
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
236,950,000
236,950,000
260,908,000
272,944,000
223,016,000
Cost of Revenue
173,715,000
173,715,000
170,984,000
161,145,000
146,808,000
Gross Profit
63,235,000
63,235,000
89,924,000
111,799,000
76,208,000
Operating Expense
67,279,000
67,279,000
66,543,000
61,308,000
50,815,000
Operating Income
-4,044,000
-4,044,000
23,381,000
50,491,000
25,393,000
Net Non Operating Interest Income Expense
55,000
55,000
-127,000
-350,000
-159,000
Pretax Income
-7,619,000
-7,619,000
22,907,000
41,323,000
20,823,000
Tax Provision
-66,000
-66,000
7,230,000
11,710,000
3,398,000
Net Income Common Stockholders
-7,553,000
-7,553,000
15,676,000
29,599,000
17,468,000
Diluted NI Available to Com Stockholders
-7,553,000
-7,553,000
15,676,000
29,599,000
17,468,000
Basic EPS
-132.77
--
275.52
519.55
306.38
Diluted EPS
-132.77
--
275.50
519.42
306.32
Basic Average Shares
56,886.64
--
56,898.21
56,971
57,014
Diluted Average Shares
56,886.64
--
56,900.18
56,984.71
57,025.33
Total Operating Income as Reported
-4,043,000
-4,043,000
23,381,000
50,490,000
25,392,000
Total Expenses
240,994,000
240,994,000
237,527,000
222,453,000
197,623,000
Net Income from Continuing & Discontinued Operation
-7,553,000
-7,553,000
15,676,000
29,599,000
17,468,000
Normalized Income
-6,532,913.77
-6,532,913.77
14,877,333.26
33,247,096
20,259,395
Interest Income
454,000
454,000
242,000
45,000
150,000
Interest Expense
399,000
399,000
369,000
395,000
309,000
Net Interest Income
55,000
55,000
-127,000
-350,000
-159,000
EBIT
-7,220,000
-7,220,000
23,276,000
41,718,000
21,132,000
EBITDA
13,650,000
13,650,000
42,970,000
56,344,000
33,626,000
Reconciled Cost of Revenue
173,715,000
173,715,000
170,984,000
161,145,000
146,808,000
Reconciled Depreciation
20,870,000
20,870,000
19,694,000
14,626,000
12,494,000
Net Income from Continuing Operation Net Minority Interest
-7,553,000
-7,553,000
15,676,000
29,599,000
17,468,000
Total Unusual Items Excluding Goodwill
-1,029,000
-1,029,000
1,167,000
-5,088,000
-3,335,000
Total Unusual Items
-1,029,000
-1,029,000
1,167,000
-5,088,000
-3,335,000
Normalized EBITDA
14,679,000
14,679,000
41,803,000
61,432,000
36,961,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-8,913.77
-8,913.77
368,333.26
-1,439,904
-543,605
3/31/2021 - 1/1/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
300244.SZ Dian Diagnostics Group Co.,Ltd.
14.47
+1.54%
603882.SS Guangzhou Kingmed Diagnostics Group Co., Ltd.
29.09
-0.10%
4694.T BML, Inc.
2,953.00
+0.96%
2268.HK WuXi XDC Cayman Inc.
36.900
+0.27%
VCYT Veracyte, Inc.
27.16
-0.88%
CRL Charles River Laboratories International, Inc.
136.73
+0.83%
GRAL GRAIL, Inc.
40.18
+3.64%
DGX Quest Diagnostics Incorporated
171.23
+0.95%
GH Guardant Health, Inc.
38.00
+2.56%
BDSX Biodesix, Inc.
0.3426
-3.74%